Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: Early transplantation is associated with improved outcome

Bone Marrow Transplantation

Volumn 21, Issue 3, 1998, Pages 255-261

  Runde, V ^a,p   De Witte, T ^b   Arnold, R ^c   Gratwohl, A ^d   Hermans, J ^e   Van Biezen, A ^e   Niederwieser, D ^f   Labopin, M ^g   Walter Noel, M P ^h   Bacigalupo, A ⁱ   Jacobsen, N ^j   Ljungman, P ^k   Carreras, E ^l   Kolb, H J ^m   Aul, C ⁿ   Apperley, J ^o  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e LEIDEN UNIVERSITY   (Netherlands)

^f UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^g HÔPITAL SAINT ANTOINE   (France)

^h LILLE UNIVERSITY HOSPITAL   (France)

ⁱ UNIVERSITY OF GENOA   (Italy)

^j Rigshospitalet   (Denmark)

^k KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^l Postgraduate School of Hematology   (Spain)

^m UNIVERSITY OF MUNICH   (Germany)

ⁿ HEINRICH HEINE UNIVERSITY   (Germany)

^o IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^p UNIVERSITY OF DUISBURG ESSEN   (Germany)

more..

Author keywords

Allogeneic bone marrow transplantation; First line treatment; HLA identical sibling; Myelodysplastic syndrome; Secondary acute myelogenous leukemia

Indexed keywords

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; DISEASE DURATION; EUROPE; FEMALE; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; INFECTION; INFECTIOUS COMPLICATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; REFRACTORY ANEMIA; RELAPSE; SCHOOL CHILD; SIBLING; SIDEROBLASTIC ANEMIA; TREATMENT OUTCOME;

EID: 0031961981     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701084     Document Type: Article

References (17)

1. Bennett J, Catovsky D, Daniel M et al. (FAB Cooperative Group) Proposals for the classification of myelodysplastic syndromes. Br J Haematol 1982; 51: 189-199.
2. Aul C, Schneider W. The role of low-dose cytosine arabinoside and aggressive chemotherapy in advanced myelodysplastic syndromes. Cancer 1989; 64: 1812-1818.
3. Aul C, Runde V, Gattermann N. All-trans retinoic acid in patients with myelodysplastic syndromes: results of a pilot study. Blood 1993; 82: 2967-2974.
4. Bagby GC, Gabourel JD, Linman JW. Glucocorticoid therapy in the preleukemic syndrome (hemopoietic dysplasia). Ann Intern Med 1980; 92: 55-58.
5. Greenberg PL. Treatment of myelodysplastic syndromes with hemopoietic growth factors. Semin Oncol 1992; 19: 106-114.
6. Fenaux P, Preudhomme C, Hebba M. The role of intensive chemotherapy in myelodysplastic syndromes. Leuk Lymphoma 1992; 8: 43-49.
7. De Witte T, Suciu S, Peetermans M et al. Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myelogenous leukemia following MDS of more than 6 months duration. A pilot study by the Leukemia Coop-erative Group of the European Organisation for Research and Treatment in Cancer. (EORTC-LCG). Leukemia 1995; 9: 1805-1810.
8. De Witte T, Zwaan F, Hermans J et al. Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group. Br J Haematol 1990; 74: 151-155.
9. De Witte T, Gratwohl A. Bone marrow transplantation for myelodysplastic syndromes and secondary leukaemias. Br J Haematol 1993; 84: 361-364.
10. Appelbaum FR, Barrall, Storb R et al. Bone marrow transplantation for patients with myelodysplasia - pretreatment variables and outcome. Ann Intern Med 1990; 112: 590-597.
11. Anderson JE, Appelbaum FR, Fisher LD et al. Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndromes. Blood 1993; 82: 677-681.
12. Longmore G, Guinan EC, Weinstein HJ et al. Bone marrow transplantation for myelodysplasia and secondary acute non-lymphoblastic leukemia. J Clin Oncol 1990; 8: 1707-1714.
13. Nevill TJ, Shepherd JD, Reece DE et al. Treatment of myelodysplastic syndromes with busulfan-cyclophosphamide conditioning followed by allogeneic BMT. Bone Marrow Transplant 1992; 10: 445-450.
14. O'Donnell MR, Nademanee AP, Snyder DS et al. Bone marrow transplantation for myelodysplastic and myeloproliferative syndromes. J Clin Oncol 1987; 5: 1822-1826.
15. Ratanatharathorn V, Karanes C, Uberti J et al. Busulfan-based regimens and allogeneic bone marrow transplantation in patients with myelodysplastic syndromes. Blood 1993; 81: 2194-2199.
16. Anasetti C, Doney KC, Storb R et al. Marrow transplantation for severe aplastic anemia. Long term outcome in fifty 'untransfused' patients. Ann Intern Med 1986; 104: 461-466.
17. Mufti GJ, Stevens JR, Oscier DG et al. Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol 1985; 59: 425-433.